New funding to support novel DNA vaccine for therapy of leishmaniasis
Funding has been awarded by the GHIT Fund to complete preclinical development and for preparing Phase I Clinical Trial.
New funding to support novel DNA vaccine for therapy of leishmaniasis
EDUFLUVAC Final Meeting
Report on Role and Impact of EU's 'Poverty-Related and Neglected Diseases' projects
Medicines Evaluation Board (MEB) to join VAC2VAC
VAC2VAC: Progress summary of first year
TRANSVAC2: Funding for European vaccine research infrastructure
Role of vaccines in combating anti-microbial resistance
Current efforts in Zika vaccines presented at Zika Virus & other Mosquito-borne Viruses conference
EDUFLUVAC workshop